Development of nanostars as a biocompatible tumor contrast agent: toward in vivo SERS imaging
Antoine D’Hollander,1–3 Evelien Mathieu,1,4 Hilde Jans,1 Greetje Vande Velde,2,3 Tim Stakenborg,1 Pol Van Dorpe,1,4 Uwe Himmelreich,2,3 Liesbet Lagae1,4 1Department of Life Science Technology, Imec, 2Department of Imaging and Pathology, Faculty of Medicine, Biomedical MRI Unit,...
Guardado en:
Autores principales: | D’Hollander A, Mathieu E, Jans H, Vande Velde G, Stakenborg T, Van Dorpe P, Himmelreich U, Lagae L |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4bb786e4d813423d9c2bcb7e7f32daeb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Gold Nanostars: A Novel Platform for Developing 211At-Labeled Agents for Targeted Alpha-Particle Therapy
por: Liu Y, et al.
Publicado: (2021) -
Photothermal ablation of inflammatory breast cancer tumor emboli using plasmonic gold nanostars
por: Crawford BM, et al.
Publicado: (2017) -
Cationic Peptide-Modified Gold Nanostars as Efficient Delivery Platform for RNA Interference Antitumor Therapy
por: Si Chen, et al.
Publicado: (2021) -
Shape-dependent antibacterial effects of non-cytotoxic gold nanoparticles
por: Penders J, et al.
Publicado: (2017) -
Stable in Biocompatible Buffers Silver Nanoisland Films for SERS
por: Alexey Skvortsov, et al.
Publicado: (2021)